Cargando…

Inflammation‐driven brain and gut barrier dysfunction in stress and mood disorders

Regulation of emotions is generally associated exclusively with the brain. However, there is evidence that peripheral systems are also involved in mood, stress vulnerability vs. resilience, and emotion‐related memory encoding. Prevalence of stress and mood disorders such as major depression, bipolar...

Descripción completa

Detalles Bibliográficos
Autores principales: Doney, Ellen, Cadoret, Alice, Dion‐Albert, Laurence, Lebel, Manon, Menard, Caroline
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290537/
https://www.ncbi.nlm.nih.gov/pubmed/33876886
http://dx.doi.org/10.1111/ejn.15239
_version_ 1784748925120413696
author Doney, Ellen
Cadoret, Alice
Dion‐Albert, Laurence
Lebel, Manon
Menard, Caroline
author_facet Doney, Ellen
Cadoret, Alice
Dion‐Albert, Laurence
Lebel, Manon
Menard, Caroline
author_sort Doney, Ellen
collection PubMed
description Regulation of emotions is generally associated exclusively with the brain. However, there is evidence that peripheral systems are also involved in mood, stress vulnerability vs. resilience, and emotion‐related memory encoding. Prevalence of stress and mood disorders such as major depression, bipolar disorder, and post‐traumatic stress disorder is increasing in our modern societies. Unfortunately, 30%–50% of individuals respond poorly to currently available treatments highlighting the need to further investigate emotion‐related biology to gain mechanistic insights that could lead to innovative therapies. Here, we provide an overview of inflammation‐related mechanisms involved in mood regulation and stress responses discovered using animal models. If clinical studies are available, we discuss translational value of these findings including limitations. Neuroimmune mechanisms of depression and maladaptive stress responses have been receiving increasing attention, and thus, the first part is centered on inflammation and dysregulation of brain and circulating cytokines in stress and mood disorders. Next, recent studies supporting a role for inflammation‐driven leakiness of the blood–brain and gut barriers in emotion regulation and mood are highlighted. Stress‐induced exacerbated inflammation fragilizes these barriers which become hyperpermeable through loss of integrity and altered biology. At the gut level, this could be associated with dysbiosis, an imbalance in microbial communities, and alteration of the gut–brain axis which is central to production of mood‐related neurotransmitter serotonin. Novel therapeutic approaches such as anti‐inflammatory drugs, the fast‐acting antidepressant ketamine, and probiotics could directly act on the mechanisms described here improving mood disorder‐associated symptomatology. Discovery of biomarkers has been a challenging quest in psychiatry, and we end by listing promising targets worth further investigation.
format Online
Article
Text
id pubmed-9290537
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-92905372022-07-20 Inflammation‐driven brain and gut barrier dysfunction in stress and mood disorders Doney, Ellen Cadoret, Alice Dion‐Albert, Laurence Lebel, Manon Menard, Caroline Eur J Neurosci Special Issue Reviews Regulation of emotions is generally associated exclusively with the brain. However, there is evidence that peripheral systems are also involved in mood, stress vulnerability vs. resilience, and emotion‐related memory encoding. Prevalence of stress and mood disorders such as major depression, bipolar disorder, and post‐traumatic stress disorder is increasing in our modern societies. Unfortunately, 30%–50% of individuals respond poorly to currently available treatments highlighting the need to further investigate emotion‐related biology to gain mechanistic insights that could lead to innovative therapies. Here, we provide an overview of inflammation‐related mechanisms involved in mood regulation and stress responses discovered using animal models. If clinical studies are available, we discuss translational value of these findings including limitations. Neuroimmune mechanisms of depression and maladaptive stress responses have been receiving increasing attention, and thus, the first part is centered on inflammation and dysregulation of brain and circulating cytokines in stress and mood disorders. Next, recent studies supporting a role for inflammation‐driven leakiness of the blood–brain and gut barriers in emotion regulation and mood are highlighted. Stress‐induced exacerbated inflammation fragilizes these barriers which become hyperpermeable through loss of integrity and altered biology. At the gut level, this could be associated with dysbiosis, an imbalance in microbial communities, and alteration of the gut–brain axis which is central to production of mood‐related neurotransmitter serotonin. Novel therapeutic approaches such as anti‐inflammatory drugs, the fast‐acting antidepressant ketamine, and probiotics could directly act on the mechanisms described here improving mood disorder‐associated symptomatology. Discovery of biomarkers has been a challenging quest in psychiatry, and we end by listing promising targets worth further investigation. John Wiley and Sons Inc. 2021-05-17 2022-05 /pmc/articles/PMC9290537/ /pubmed/33876886 http://dx.doi.org/10.1111/ejn.15239 Text en © 2021 The Authors. European Journal of Neuroscience published by Federation of European Neuroscience Societies and John Wiley & Sons Ltd https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Special Issue Reviews
Doney, Ellen
Cadoret, Alice
Dion‐Albert, Laurence
Lebel, Manon
Menard, Caroline
Inflammation‐driven brain and gut barrier dysfunction in stress and mood disorders
title Inflammation‐driven brain and gut barrier dysfunction in stress and mood disorders
title_full Inflammation‐driven brain and gut barrier dysfunction in stress and mood disorders
title_fullStr Inflammation‐driven brain and gut barrier dysfunction in stress and mood disorders
title_full_unstemmed Inflammation‐driven brain and gut barrier dysfunction in stress and mood disorders
title_short Inflammation‐driven brain and gut barrier dysfunction in stress and mood disorders
title_sort inflammation‐driven brain and gut barrier dysfunction in stress and mood disorders
topic Special Issue Reviews
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290537/
https://www.ncbi.nlm.nih.gov/pubmed/33876886
http://dx.doi.org/10.1111/ejn.15239
work_keys_str_mv AT doneyellen inflammationdrivenbrainandgutbarrierdysfunctioninstressandmooddisorders
AT cadoretalice inflammationdrivenbrainandgutbarrierdysfunctioninstressandmooddisorders
AT dionalbertlaurence inflammationdrivenbrainandgutbarrierdysfunctioninstressandmooddisorders
AT lebelmanon inflammationdrivenbrainandgutbarrierdysfunctioninstressandmooddisorders
AT menardcaroline inflammationdrivenbrainandgutbarrierdysfunctioninstressandmooddisorders